Kimberly Pennix
SAM.gov · MD
Contact
- kimberly.pennix@fda.hhs.gov
- Phone
- 2404029703
- Title
- —
- Type
- primary
Open solicitations
- Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo ValidationSAM.govDue Sep 10, 2026
- UHPLC with PFAS KitSAM.govArkansasDue Aug 21, 2026
- Hive 2.0: Expansion of FDA ARGOSSAM.govDue Jul 2, 2026